Home / Inspections / 1200726

FDA Inspection 1200726 — Spectrum Laboratory Products, Inc.

Spectrum Laboratory Products, Inc. — FEI 2246824

The FDA completed an inspection of Spectrum Laboratory Products, Inc. on March 24, 2023 in New Brunswick, NJ. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
March 24, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
New Brunswick, NJ (United States)

Facility

Other inspections at this facility

  • 1261606 (VAI Wed Feb 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1149194 (OAI Wed Jul 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1083125 (NAI Tue Mar 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 974105 (VAI Mon Mar 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 845759 (NAI Fri Aug 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources